You are here

Company Monitoring Page for Roche

job ratings for Roche

12/28/23

industry:

company:

Roche

job rating:

1

Roche ordered Genentech to work on application of AI in drug discovery. At Roche no one really understands it, but to their surprise Genentech is not up to the task after years of dependency on Roche.The made an agreement with Invidia who will be the real beneficiary by familiarizing itself with this domain.

latest headlines for company on cafepharma

Roche wins FDA OK for targeted drug in early lung cancer

BioPharma Dive

Fri, 04/19/24 - 11:40 am

Tags:

Roche, Alecensa, ALK inhibitors, FDA, non-small cell lung cancer

Roche’s Early Alzheimer’s Blood Test Gets FDA Breakthrough Device Designation

Xtalks

Thu, 04/18/24 - 10:28 pm

Tags:

Roche, FDA, Medtech, Eli Lilly, Elecsys pTau217, Alzheimer's disease, diagnostics

Roche touts near-complete suppression of multiple sclerosis relapse for injectable Ocrevus

Fierce Pharma

Wed, 04/17/24 - 11:33 am

Tags:

Roche, Ocrevus, MS, multiple sclerosis, AAN

Pfizer's academic-partnered R&D unit is scrapped as part of cost-cutting measures

Fierce Biotech

Wed, 04/17/24 - 11:20 am

Tags:

Pfizer, R&D, Roche

Roche’s Columvi offers survival benefit in Phase III DLBCL trial

Clinical Trials Arena

Mon, 04/15/24 - 11:07 am

Tags:

Roche, clinical trials, Columvi, DLBCL

Roche, Adaptimmune part ways on cell therapy research

BioPharma Dive

Sun, 04/14/24 - 01:26 pm

Tags:

Roche, Genentech, cell therapy, cancer, Adaptimmune

FDA puts breakthrough tag on Roche, Lilly Alzheimer’s test

Pharmaphorum

Thu, 04/11/24 - 10:52 am

Tags:

diagnostics, Roche, Eli Lilly, Alzheimer's disease, FDA, breakthrough designation

5 Successful Phase III Oncology Trials in Q1

BioSpace

Tue, 04/9/24 - 11:50 am

Tags:

oncology, clinical trials, Bristol Myers Squibb, Opdivo, Yervoy, liver cancer, Pfizer, DLBCL, Adcetris, Asieris, HSIL, APL-1702, cervical cancer, Novocure, non-small cell lung cancer, Roche, Genentech, Tecentriq, esophageal squamous cell carcinoma

Roche autoimmune disease drug disappoints in closely watched trial

BioPharma Dive

Thu, 03/21/24 - 06:36 pm

Tags:

Roche, Chugai, clinical trials, myasthenia gravis, Enspryng

Pfizer's Braftovi to command 42% share of BRAF inhibitors melanoma market by 2028

Biopharma Reporter

Thu, 03/21/24 - 11:37 am

Tags:

Pfizer, Braftovi, Roche, Zelboraf, melanoma

BMS racks up phase III win in liver cancer targeted by AstraZeneca and Roche

BioSpace

Wed, 03/20/24 - 11:51 am

Tags:

Bristol Myers Squibb, immuno-oncology, Opdivo, Yervoy, liver cancer, AstraZeneca, Roche

Lonza adds biologics capacity with $1.2bn Roche deal

Pharmaphorum

Wed, 03/20/24 - 11:17 am

Tags:

Roche, Lonza, drug manufacturing, Switzerland, CDMOs

Roche Plots Neuro Comeback with Promising Mid-Stage Alzheimer’s Data

BioSpace

Tue, 03/12/24 - 11:14 am

Tags:

Roche, Alzheimer's disease, monoclonal antibodies

Roche to take on Abbott, Dexcom with its first CGM

Medtech Dive

Fri, 03/8/24 - 11:13 am

Tags:

Medtech, Roche, CGMs, diabetes, Abbott Labs, DexCom, Accu-Chek Smartguide

Asthma Drug Xolair Now Indicated For Food Allergies: Next Challenge Is Insurer Coverage

Forbes

Wed, 03/6/24 - 11:25 am

Tags:

Roche, Novartis, Xolair, insurers, food allergies

Roche, Alnylam say blood pressure drug succeeds in mid-stage trial

Reuters

Tue, 03/5/24 - 11:07 am

Tags:

Roche, Alnylam Pharmaceuticals, clinical trials, hypertension, zilebesiran

Roche Reassesses Esbriet's Future Amidst Generic Drug Competition

Medriva

Tue, 02/27/24 - 11:28 am

Tags:

Roche, generics, Esbriet, IPF

Roche evaluates options for its lung disease drug

Reuters

Mon, 02/26/24 - 05:12 pm

Tags:

Roche, Esbriet, lung cancer

6 first-half 2024 oncology data readouts to watch

BioSpace

Mon, 02/26/24 - 11:20 am

Roche's Xolair reduces reactions to severe food allergies in study

Reuters

Sun, 02/25/24 - 05:36 pm

Tags:

Roche, Novartis, Xolair, clinical trials, food allergies

Pages

last 30 twitter posts